ViewRay (VRAYQ) Competitors Add Compare Share Share Competitors Stock AnalysisChartCompetitorsFinancialsOptions ChainSEC FilingsTrends VRAYQ vs. SDCCQ, GMVDF, AHPI, NMRD, MOTS, BRSH, DRTSW, ANZUW, BBLGW, and BRSHWShould you be buying ViewRay stock or one of its competitors? The main competitors of ViewRay include SmileDirectClub (SDCCQ), G Medical Innovations (GMVDF), Allied Healthcare Products (AHPI), Nemaura Medical (NMRD), Motus GI (MOTS), Bruush Oral Care (BRSH), Alpha Tau Medical (DRTSW), Anzu Special Acquisition Corp I (ANZUW), Bone Biologics (BBLGW), and Bruush Oral Care (BRSHW). These companies are all part of the "medical equipment" industry. ViewRay vs. SmileDirectClub G Medical Innovations Allied Healthcare Products Nemaura Medical Motus GI Bruush Oral Care Alpha Tau Medical Anzu Special Acquisition Corp I Bone Biologics Bruush Oral Care ViewRay (NASDAQ:VRAYQ) and SmileDirectClub (NASDAQ:SDCCQ) are both small-cap medical companies, but which is the better business? We will compare the two businesses based on the strength of their earnings, institutional ownership, community ranking, dividends, risk, profitability, analyst recommendations, valuation and media sentiment. Which has better earnings and valuation, VRAYQ or SDCCQ? SmileDirectClub has higher revenue and earnings than ViewRay. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioViewRay$102.21M0.00-$107.33MN/AN/ASmileDirectClub$470.74M0.00-$86.40MN/AN/A Does the media favor VRAYQ or SDCCQ? In the previous week, ViewRay's average media sentiment score of 0.00 equaled SmileDirectClub'saverage media sentiment score. Company Overall Sentiment ViewRay Neutral SmileDirectClub Neutral Is VRAYQ or SDCCQ more profitable? Company Net Margins Return on Equity Return on Assets ViewRayN/A N/A N/A SmileDirectClub N/A N/A N/A Do institutionals & insiders believe in VRAYQ or SDCCQ? 15.5% of ViewRay shares are held by institutional investors. Comparatively, 0.1% of SmileDirectClub shares are held by institutional investors. 2.5% of ViewRay shares are held by insiders. Comparatively, 64.7% of SmileDirectClub shares are held by insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a stock is poised for long-term growth. Which has more risk and volatility, VRAYQ or SDCCQ? ViewRay has a beta of 0.9, meaning that its stock price is 10% less volatile than the S&P 500. Comparatively, SmileDirectClub has a beta of 1.9, meaning that its stock price is 90% more volatile than the S&P 500. Does the MarketBeat Community believe in VRAYQ or SDCCQ? ViewRay and SmileDirectClub both received 0 outperform votes by MarketBeat users. CompanyUnderperformOutperformViewRayN/AN/ASmileDirectClubN/AN/A SummarySmileDirectClub beats ViewRay on 4 of the 5 factors compared between the two stocks. Ad ProsperityPubCrypto’s hidden gem + greatest crypto bull run in history = $$$?You don’t actually want to buy Bitcoin this time around. That’s because there’s a better way to take advantage of this new bull market… One market expert calls it Crypto’s Hidden Gem And it’s a new way that has given folks like you and me the chance to see bigger and faster moves than the traditional way of buying Bitcoin… That means if you’ve stayed away from Bitcoin and crypto because it's confusing or seems risky… This is a much safer and better approach to ride this years’ crypto bull run. Because believe it or not… The 2024 crypto bull run is one you DON’T want to miss.Click Here to get the full details about Crypto’s Hidden Gem Get ViewRay News Delivered to You Automatically Sign up to receive the latest news and ratings for VRAYQ and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart VRAYQ vs. The Competition Export to ExcelMetricViewRayElectromedical equipment IndustryMedical SectorNASDAQ ExchangeMarket Cap$18,000.00$3.07B$5.13B$9.07BDividend YieldN/A1.75%5.08%4.23%P/E RatioN/A17.1689.5817.17Price / SalesN/A50.221,116.12116.95Price / CashN/A39.9142.8237.86Price / BookN/A3.724.774.78Net Income-$107.33M$89.83M$120.15M$225.60M ViewRay Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)VRAYQViewRayN/AN/AN/AN/A$18,000.00$102.21M0.00300SDCCQSmileDirectClubN/A$0.00-50.0%N/A-96.0%$40,000.00$470.74M0.002,700Gap DownGMVDFG Medical InnovationsN/AN/AN/AN/A$26,000.00$4.42M0.0072AHPIAllied Healthcare ProductsN/A$0.00+∞N/AN/A$16,000.00$27.05M0.00150News CoverageNMRDNemaura Medical1.3376 of 5 starsN/AN/A-99.9%$8,000.00$3,017.000.0040Gap DownMOTSMotus GIN/A$0.00+50.0%N/A-100.0%$2,000.00$319,000.000.0030Gap DownBRSHBruush Oral CareN/A$0.00flatN/A-98.8%$1,000.00$2.92M0.0011Gap DownDRTSWAlpha Tau MedicalN/A$0.21-15.3%N/A+68.4%$0.00N/A0.0080Gap UpANZUWAnzu Special Acquisition Corp IN/A$0.09-1.1%N/A+51.7%$0.00N/A0.002BBLGWBone BiologicsN/A$27.80flatN/A+929.6%$0.00N/A0.002BRSHWBruush Oral CareN/A$0.01-1.8%N/AN/A$0.00$2.92M0.0011 Related Companies and Tools Related Companies SmileDirectClub Alternatives G Medical Innovations Alternatives Allied Healthcare Products Alternatives Nemaura Medical Alternatives Motus GI Alternatives Bruush Oral Care Alternatives Alpha Tau Medical Alternatives Anzu Special Acquisition Corp I Alternatives Bone Biologics Alternatives Bruush Oral Care Alternatives Top 10 Stock Comparisons Bank Stocks Artificial Intelligence Stocks Toy Stocks Growth Stocks Airline Stocks Chinese Stocks EV Charging Stocks Defense Stocks Lithium Stocks Pharmaceutical Stocks This page (NASDAQ:VRAYQ) was last updated on 12/22/2024 by MarketBeat.com Staff From Our PartnersThis Crypto Is Set to Explode in DecemberIt's a groundbreaking opportunity that could be poised for extraordinary gains. The catalyst behind this su...Crypto 101 Media | SponsoredWARNING: “Buffett Indicator” flashing for first time in 50 yearsWarren Buffett has sold a staggering $97 billion worth of stocks this year... But why? Our research indi...Behind the Markets | SponsoredYour bank is lying to you.You might think you have your money in a high-yield savings account, but do you really? The national average A...MyBankTracker | SponsoredRare "crisis signal" triggers for third time in U.S. marketA rare pattern has just repeated for the third time in U.S. history. The last two times this happened, the...Stansberry Research | SponsoredCould This Tiny Device Help You Make an Extra $30k a Year?I believe it’s going to power Elon Musk’s next AI revolution… A revolution he believes will be worth more t...Brownstone Research | SponsoredVladimir Lenin was right…The Magnificent 7 could be in for a world of pain… And the insiders know it. It’s why Jeff Bezos just sold ...Porter & Company | SponsoredHOTTEST TRADER IN AMERICA 🔥🔥🔥Ready for a rocket ride this weekend? After alerting his readers to a tiny $2 stock called Bright Minds Bio...Timothy Sykes | SponsoredBuffett's Oil Bet + This 22% Dividend PlayWarren Buffett has been quietly amassing a massive position in oil stocks. But while Buffett's picks (Occid...Investors Alley | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding ViewRay, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share ViewRay With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.